Effects of SU5416 and a vascular endothelial growth factor neutralizing antibody on wear debris-induced inflammatory osteolysis in a mouse model

References

• BerryDJHarmsenWSCabanelaMEMorreyBFTwenty-five-year survivorship of two thousand consecutive primary Charnley total hip replacements: Factors affecting survivorship of acetabular and femoral componentsJ Bone Joint Surg Am200284217117711861721
   PubMed Web of Science ®Google Scholar
• KeenerJDCallaghanJJGoetzDDPedersonDRSullivanPMJohnstonRCTwenty-five-year results after Charnley total hip arthroplasty in patients less than fifty years old: A concise follow-up of a previous reportJ Bone Joint Surg Am200385-A61066107212784004
   PubMed Web of Science ®Google Scholar
• BauerTWParticles and peri-implant bone resorptionClin Orthop Relat Res200240513814312461365
   PubMed Web of Science ®Google Scholar
• Al SaffarNMahJTKadoyaYRevellPANeovascularisation and the induction of cell adhesion molecules in response to degradation products from orthopaedic implantsAnn Rheum Dis19955432012087538286
   PubMed Web of Science ®Google Scholar
• GoodsellDSThe molecular perspective: VEGF and angiogenesisOncologist20027656957012490744
   PubMed Web of Science ®Google Scholar
• HarryLEPaleologEMFrom the cradle to the clinic: VEGF in developmental, physiological, and pathological angiogenesisBirth Defects Res Part C Embryo Today2003694363374
   PubMedGoogle Scholar
• WaltenbergerJClaesson-WelshLSiegbahnAShibuyaMHeldinCHDifferent signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factorJ Biol Chem19942694326988269957929439
   PubMed Web of Science ®Google Scholar
• KunstfeldRHirakawaSHongYKInduction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasiaBlood200410441048105715100155
   PubMed Web of Science ®Google Scholar
• NakagawaMKanedaTArakawaTVascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclastsFEBS Lett2000473216116410812066
   PubMed Web of Science ®Google Scholar
• HenriksenKKarsdalMDelaisseJMEngsigMTRANKL and vascular endothelial growth factor (VEGF) induce osteoclast chemotaxis through an ERK1/2-dependent mechanismJ Biol Chem200327849487454875314506249
   PubMed Web of Science ®Google Scholar
• GilesFJStopeckATSilvermanLRSU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromesBlood2003102379580112649163
   PubMed Web of Science ®Google Scholar
• RenWPYangSWooleyPHA novel murine model of orthopaedic wear debris-associated osteolysisScand J Rheumatology2004335349357
   PubMed Web of Science ®Google Scholar
• RenWZhangRMarkelDCBlockade of vascular endothelial growth factor activity suppresses wear debris-induced inflammatory osteolysisJ Rheumatol2007341273517216676
   PubMed Web of Science ®Google Scholar
• RenWPMarkelDCZhangRAssociation between UHMWPE particle-induced inflammatory osteoclastogenesis and expression of RANKL, VEGF, and Flt-1 in vivoBiomaterials200627305161516916814378
   PubMed Web of Science ®Google Scholar
• WooleyPHMorrenRAndaryJInflammatory responses to orthopaedic biomaterials in the murine air pouchBiomaterials200223251752611761173
   PubMed Web of Science ®Google Scholar
• RenWPWuBMaytonLWooleyPHPolyethylene and methyl methacrylate particle-stimulated inflammatory tissue and macrophages up-regulate bone resorption in a murine neonatal bone resorption in a murine neonatal calvaria in vitro organ systemJ Orthop Res20022051031103712382970
   PubMed Web of Science ®Google Scholar
• WooleyPHSchwarzEMAseptic looseningGene Ther200411440240714724679
   PubMed Web of Science ®Google Scholar
• MiyanishiKTrindadeMCMaTGoodmanSBSchurmanDJSmithRLPeriprosthetic osteolysis: Induction of vascular endothelial growth factor from human monocyte/macrophages by orthopaedic biomaterial particlesJ Bone Miner Res20031891573158312968666
   PubMed Web of Science ®Google Scholar
• JellGMRAl-SaffarNDoes a pro-angiogenic state exist in the bone-implant interface of aseptically loosened joint prosthesisJ Mat Sci Mater Med20011210–1210691073
   Web of Science ®Google Scholar
• IkedaMHosodaYHiroseSOkadaYIkedaEExpression of vascular endothelial growth factor isoforms and their receptors Flt-1, KDR, and neuropilin-1 in synovial tissues of rheumatoid arthritisJ Pathol2000191442643310918218
   PubMed Web of Science ®Google Scholar
• De BandtMBen MahdiMHOllivierVBlockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K/BxN model of rheumatoid arthritisJ Immunol200317194853485914568965
   PubMed Web of Science ®Google Scholar
• FavaRAOlsenNJSpencer-GreenGVascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissueJ Exp Med199418013413468006592
   PubMed Web of Science ®Google Scholar
• HaywoodLMcWilliamsDFPearsonCIInflammation and angiogenesis in osteoarthritisArthritis Rheum20034882173217712905470
   PubMed Web of Science ®Google Scholar
• XiaYPLiBHyltonDDetmarMYancopoulosGDRudgeJSTransgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasisBlood2003102116116812649136
   PubMed Web of Science ®Google Scholar
• LuttunATjwaMCarmelietPPlacental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): Novel therapeutic targets for angiogenic disordersAnn N Y Acad Sci2002979809312543719
   PubMed Web of Science ®Google Scholar
• SteaSVisentinMGranchiDCytokines and osteolysis around total hip prosthesesCytokine200012101575157911023677
   PubMed Web of Science ®Google Scholar
• ChildsLMGoaterJJO’KeefeRJSchwarzEMEfficacy of etanercept for wear debris-induced osteolysisJ Bone Miner Res200116233834711204434
   PubMed Web of Science ®Google Scholar
• JonesLCFrondozaCHungerfordDSImmunohistochemical evaluation of interface membranes from failed cemented and uncemented acetabular componentsJ Biomed Mater Res199948688989810556856
   PubMed Web of Science ®Google Scholar
• MinJKKimYMKimYMVascular endothelial growth factor up-regulates expression of receptor activator of NF-kappa B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligandJ Biol Chem200327841395483955712893832
   PubMed Web of Science ®Google Scholar
• NiidaSKakuMAmanoHVascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorptionJ Exp Med1999190229329810432291
   PubMed Web of Science ®Google Scholar
• KodamaINiidaSSanadaMEstrogen regulates the production of VEGF for osteoclast formation and activity in op/op miceJ Bone Miner Res200419220020614969389
   PubMed Web of Science ®Google Scholar
• KakuMKohnoSKawataTEffects of vascular endothelial growth factor on osteoclast induction during tooth movement in miceJ Dent Res200180101880188311706945
   PubMed Web of Science ®Google Scholar
• SawanoAIwaiSSakuraiYFlt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humansBlood200197378579111157498
   PubMed Web of Science ®Google Scholar
• ArrasMItoWDScholzDWinklerBSchaperJSchaperWMonocyte activation in angiogenesis and collateral growth in the rabbit hindlimbJ Clin Invest1998101140509421464
   PubMed Web of Science ®Google Scholar
• BarleonBSozzaniSZhouDWeichHAMantovaniAMarmeDMigration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1Blood1996878333633438605350
   PubMed Web of Science ®Google Scholar
• MatsumotoYTanakaKHirataGPossible involvement of the vascular endothelial growth factor-Flt-1-focal adhesion kinase pathway in chemotaxis and the cell proliferation of osteoclast precursor cells in arthritic jointsJ Immunol2002168115824583112023386
   PubMed Web of Science ®Google Scholar
• SukbuntherngJCroppGHannahAWagnerGSShawverLKAntonianLPharmacokinetics and interspecies scaling of a novel VEGF receptor inhibitor, SU5416J Pharm Pharmacol200153121629163611804393
   PubMed Web of Science ®Google Scholar